Cost-effectiveness of the implementation of [ 68 Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging.

Esmée C A van der SarWillem R KeustersLudwike W M van KalmthoutArthur J A T BraatBart de KeizerGeert W J FrederixAnko KooistraJules LavalayeMarnix G E H LamHarm H E van Melick

Published in: Insights into imaging (2022)

Ga]Ga-PSMA-11 PET/CT saves cost but results in small QALY loss due to the rate of false positive findings.

Keyphrases

pet ct
prostate cancer
positron emission tomography
primary care
healthcare
radical prostatectomy
quality improvement